CIM Investment Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

CIM Investment Management’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,522	Closed	-$256K	–	318
2021 Q3	$256K	Hold	7,522	–	–	0.08%	232
2021 Q2	$275K	Hold	7,522	–	–	0.09%	227
2021 Q1	$337K	Sell	7,522 -449	-6%	-$20.9K	0.11%	186
2020 Q4	$455K	Buy	7,971 +3,831	+93%	+$227K	0.15%	139
2020 Q3	$212K	Buy	4,140 +59	+1%	+$2.89K	0.08%	229
2020 Q2	$244K	Buy	+4,081	New	+$218K	0.1%	201

Other funds holding DCPH

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CIM Investment Management's DCPH Position: Q4 2021 in Review

CIM Investment Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 7,522 shares — an estimated $256K sold.

CIM Investment Management first reported a position in DCPH in Q2 2020 and held it in 6 quarters. The position peaked at $455K in Q4 2020. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

CIM Investment Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
CIM Investment Management sold 7,522 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $256K.
CIM Investment Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
CIM Investment Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $455K in Q4 2020.
140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on CIM Investment Management's 13F filing for Q4 2021, filed 2 Feb 2022.